Brian Wolpin
Tracked across 1 events · 74 articles · First seen May 29, 2026 · Last active Jun 09, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Brian Wolpin, from the Dana–Farber Cancer Institute, presented the findings of the daraxonrasib study and advocated for its adoption as a new standard of care.
May 29, 2026 · 74 articles
ERGEN INTELLIGENCE
Track Brian Wolpin live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard